LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Home・Stock List・Lyell Immunopharma Inc
Search

Lyell Immunopharma Inc

Closed

13.12 3.72

Buy

Price update 10 Jun 2026, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

12.11

Max

13.24

Key metrics

By Trading Economics

Income

117M

-24M

Sales

-4K

2K

EPS

-1.1

Profit margin

-1,207,650

Employees

161

EBITDA

16M

-44M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+195.28% upside

Dividends

By Acuity

Next Earnings

10 Aug 2026

Market Stats

By TradingEconomics

Market Cap

-204M

279M

Previous open

9.4

Previous close

13.12

Lyell Immunopharma Inc Chart

Past performance is not a reliable indicator of future results.

Related News

10 Jun 2026, 23:36 UTC

Correction to Oracle Reports Higher 4Q Profit Article

Read

10 Jun 2026, 23:19 UTC

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

Read

10 Jun 2026, 23:09 UTC

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

Read

10 Jun 2026, 23:04 UTC

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

Read

10 Jun 2026, 20:44 UTC

Caterpillar Raises Quarterly Dividend 8%

Read

10 Jun 2026, 23:49 UTC

Elliott: Northern Star Should Take No Options Off The Table

Read

10 Jun 2026, 23:48 UTC

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

Read

10 Jun 2026, 23:48 UTC

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

Read

10 Jun 2026, 23:47 UTC

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

Read

10 Jun 2026, 23:47 UTC

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

Read

10 Jun 2026, 23:46 UTC

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

Read

10 Jun 2026, 23:38 UTC

Global Equities Roundup: Market Talk

Read

10 Jun 2026, 23:38 UTC

Global Forex and Fixed Income Roundup: Market Talk

Read

10 Jun 2026, 23:38 UTC

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

Read

10 Jun 2026, 23:32 UTC

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

Read

10 Jun 2026, 23:20 UTC

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

Read

10 Jun 2026, 22:05 UTC

Correction to Bank of Canada Stays on Hold Market Talk

Read

10 Jun 2026, 21:57 UTC

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

Read

10 Jun 2026, 21:52 UTC

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

Read

10 Jun 2026, 21:35 UTC

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

Read

10 Jun 2026, 21:22 UTC

Oracle Stock Slides on Increased Capital Spending -- WSJ

Read

10 Jun 2026, 20:50 UTC

Tech, Media & Telecom Roundup: Market Talk

Read

10 Jun 2026, 20:50 UTC

Financial Services Roundup: Market Talk

Read

10 Jun 2026, 20:50 UTC

Basic Materials Roundup: Market Talk

Read

10 Jun 2026, 20:50 UTC

Health Care Roundup: Market Talk

Read

10 Jun 2026, 20:39 UTC

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

Read

10 Jun 2026, 20:34 UTC

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

Read

10 Jun 2026, 20:33 UTC

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

Read

10 Jun 2026, 20:33 UTC

Global Equities Roundup: Market Talk

Read

10 Jun 2026, 20:33 UTC

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Read

Peer Comparison

Price change

Lyell Immunopharma Inc Forecast

Price Target

By TipRanks

195.28% upside

12 Months Forecast

Average 37.5 USD  195.28%

High 49 USD

Low 12 USD

Based on 4 Wall Street analysts offering 12 month price targets forLyell Immunopharma Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

4 ratings

3

Buy

0

Hold

1

Sell

Based on 4 analysts giving stock ratings to Lyell Immunopharma Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,136.41

↓-0.5%

JNJ

Johnson and Johnson

238.85

↑ +0.91%

ABBV

AbbVie Inc

225.29

↑ +0.05%

UNH

UnitedHealth Group Inc

407.06

↓-1.28%

MRK

Merck & Co Inc.

119

↓-0.38%
help-icon Live chat